Track topics on Twitter Track topics that are important to you
Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry ("MS") instruments, has developed proof of concept workflows to analyse in real-time complex samples from bioreactors, which could enable customers to achieve significant costs and time savings. An independent laboratory was engaged to compare the use of Microsaic's MiD® ProteinID technology as an in-situ technique for measuring small and large molecules....NEXT ARTICLE
Multiple Sclerosis MS
Multiple sclerosis (MS) is the most common disabling neurological condition affecting 100,000 young adults in the UK. The condition results from autoimmune damage to myelin, causing interference in nerve signaling. Symptoms experienced depend on the pa...